Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04233021
Title Study of Osimertinib in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation (ORBITAL)
Acronym ORBITAL
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Intergroupe Francophone de Cancerologie Thoracique
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.